Clazakizumab: Difference between revisions
Content deleted Content added
m o |
Anypodetos (talk | contribs) Drugbox |
||
| Line 1: | Line 1: | ||
{{drugbox |
|||
| type = mab |
|||
| image = |
|||
| source = humanized |
|||
| target = [[interleukin-6|IL-6]] |
|||
| CAS_number = |
|||
| ATC_prefix = none |
|||
| ATC_suffix = |
|||
| PubChem = |
|||
| DrugBank = |
|||
| chemical_formula = |
|||
| molecular_weight = |
|||
| bioavailability = |
|||
| protein_bound = |
|||
| metabolism = |
|||
| elimination_half-life = |
|||
| excretion = |
|||
| pregnancy_AU = |
|||
| pregnancy_US = |
|||
| pregnancy_category= |
|||
| legal_AU = |
|||
| legal_CA = |
|||
| legal_UK = |
|||
| legal_US = |
|||
| legal_status = investigational |
|||
| routes_of_administration = infusion |
|||
}} |
|||
'''ALD518''' a humanized [[monoclonal antibody]] against [[interleukin-6]]. |
'''ALD518''' a humanized [[monoclonal antibody]] against [[interleukin-6]]. |
||
Revision as of 08:50, 11 November 2009
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | humanized |
| Target | IL-6 |
| Clinical data | |
| Routes of administration | infusion |
| ATC code |
|
| Legal status | |
| Legal status |
|
ALD518 a humanized monoclonal antibody against interleukin-6.
Clinical trials
Cancer
Phase II trial for advanced cancer.[1]
Rheumatoid arthritis
Phase II trial for rheumatoid arthritis.[2]
References
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |